ClinicalTrials.gg
DrugBiological

Hepatitis B hyperimmune globulin clinical trials

Also written HBIG.

Includes 2 studies of BT088 immunoglobulin, human.

studies test it
13
open now
2
in phase 3
3
first study started
1999

How each study uses hepatitis B hyperimmune globulin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the hepatitis B hyperimmune globulin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Sept 1977 · Bayhep B, Hyperhep B S/D · BLA 101146 (FDA, Purple Book)
European Union
30 Nov 2009 · Zutectra · EMEA/H/C/001089 (EMA; as BT088 immunoglobulin, human)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Hepatitis B immunoglobulin (HBIg)
2

Other names

HBIG
3
Hepatitis B Immune Globulin
2

Studies by the year they started

13 studies that test it; most in 2010 (2)

Studies that test hepatitis B hyperimmune globulin, by start year
YearStudies
19991
20031
20051
20081
20091
20102
20122
20191
20221
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
1
Phase 2
3
Phase 3
3
Phase 4
4
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 7

Biotest Pharmaceuticals Corporation (1) · GlaxoSmithKline (1) · Instituto Grifols, S.A. (1) · Georgetown University (1) · SK Chemicals Co., Ltd. (1) · Biotest (1) · Xi'an Jiaotong University (1) · Cangene Corporation (1)

Often tested with

Tested in the same studies.

Vaccines (1) · Entecavir (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test hepatitis B hyperimmune globulin.

Studies

Open first, then newest update. How each study uses hepatitis B hyperimmune globulin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Given beside what is tested · 1 — hepatitis B hyperimmune globulin is usual care or a partner of the new treatment

Codes

What other systems call hepatitis B hyperimmune globulin · ClinicalTrials.gg INT003207

  • MeSH (NLM) C045213hepatitis B hyperimmune globulinOne source NLM
  • RxNorm 26744One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.